Free Trial

Ethic Inc. Takes Position in Dolby Laboratories $DLB

Dolby Laboratories logo with Consumer Discretionary background

Key Points

  • Ethic Inc. has invested approximately $536,000 in Dolby Laboratories by acquiring 6,644 shares, showcasing institutional interest in the company.
  • Dolby Laboratories' CEO and EVP recently sold a significant number of shares, with CEO Kevin J. Yeaman selling 39,875 shares for nearly $3 million, indicating a 25.79% reduction in his ownership.
  • Analysts have varied opinions on Dolby's stock, with price targets ranging from $95 to $114, with an overall average rating of "Buy" and a consensus price target of $103.
  • Want stock alerts on Dolby Laboratories? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Ethic Inc. bought a new position in Dolby Laboratories (NYSE:DLB - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,644 shares of the electronics maker's stock, valued at approximately $536,000.

Other large investors have also recently bought and sold shares of the company. Palogic Value Management L.P. raised its holdings in shares of Dolby Laboratories by 6.4% during the fourth quarter. Palogic Value Management L.P. now owns 3,888 shares of the electronics maker's stock valued at $304,000 after buying an additional 235 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Dolby Laboratories during the fourth quarter valued at approximately $1,872,000. Barclays PLC raised its holdings in shares of Dolby Laboratories by 106.6% during the fourth quarter. Barclays PLC now owns 68,646 shares of the electronics maker's stock valued at $5,359,000 after buying an additional 35,416 shares during the last quarter. Mariner LLC raised its holdings in shares of Dolby Laboratories by 31.2% during the fourth quarter. Mariner LLC now owns 9,393 shares of the electronics maker's stock valued at $734,000 after buying an additional 2,236 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co raised its holdings in shares of Dolby Laboratories by 0.5% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 44,954 shares of the electronics maker's stock valued at $3,511,000 after buying an additional 216 shares during the last quarter. Institutional investors own 58.56% of the company's stock.

Dolby Laboratories Stock Down 0.9%

Dolby Laboratories stock traded down $0.68 during mid-day trading on Wednesday, hitting $72.36. The company's stock had a trading volume of 100,140 shares, compared to its average volume of 429,971. The stock has a market capitalization of $6.93 billion, a P/E ratio of 26.49 and a beta of 0.91. Dolby Laboratories has a twelve month low of $68.24 and a twelve month high of $89.66. The stock's fifty day moving average price is $74.28 and its two-hundred day moving average price is $76.46.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.06. The firm had revenue of $315.55 million for the quarter, compared to analyst estimates of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm's quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Equities analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.8%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories's payout ratio is presently 48.35%.

Insiders Place Their Bets

In other news, EVP Mark Andrew Sherman sold 15,000 shares of the business's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $75.02, for a total transaction of $1,125,300.00. Following the transaction, the executive vice president directly owned 62,397 shares in the company, valued at $4,681,022.94. The trade was a 19.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Kevin J. Yeaman sold 39,875 shares of the business's stock in a transaction on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the transaction, the chief executive officer owned 114,725 shares in the company, valued at approximately $8,583,724.50. This represents a 25.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 148,049 shares of company stock worth $11,045,581. Corporate insiders own 38.39% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on DLB shares. Tigress Financial lifted their price target on Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a report on Friday, August 15th. Wall Street Zen cut Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Barrington Research reiterated an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Friday, May 2nd. Finally, Rosenblatt Securities reiterated a "buy" rating and set a $95.00 price objective on shares of Dolby Laboratories in a research note on Friday, August 1st. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Dolby Laboratories presently has an average rating of "Buy" and a consensus price target of $103.00.

Get Our Latest Stock Analysis on Dolby Laboratories

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines